Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -69.79% is in line with its 4-year average of -73.35%, near the low end of its 4-year range (-106.61%–188.02%).
As of the fiscal period ended Tuesday, June 30, 2026. 19.77% above its 12-month average of -86.99%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -69.79%.
RETURN ON EQUITY (ROE)
-69.79%
RETURN ON EQUITY (ROE) AVG TTM
-86.99%
RETURN ON EQUITY (ROE) AVG 3Y
-75.38%
RETURN ON EQUITY (ROE) AVG 5Y
-73.35%
RETURN ON EQUITY (ROE) AVG 10Y
-73.35%
RETURN ON EQUITY (ROE) AVG 15Y
-73.35%
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+19.77%
CURRENT VS 3Y AVG
+7.41%
CURRENT VS 5Y AVG
+4.85%
CURRENT VS 10Y AVG
+4.85%
CURRENT VS 15Y AVG
+4.85%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.06%
median of 381 covered companies
CURRENT VS SECTOR MEDIAN
-111.11%
vs the sector median at left
Creative Medical Technology Holdings, Inc.
Market Cap
$2.37M
Return on Equity (ROE)
-69.79%
TTM Avg
-86.99%
3Y Avg
-75.38%
5Y Avg
-73.35%
Market Cap
$2.36M
Return on Equity (ROE)
-1160.10%
TTM Avg
-528.10%
3Y Avg
-389.86%
5Y Avg
-336.02%
Market Cap
$2.47M
Return on Equity (ROE)
-391.26%
TTM Avg
-355.49%
3Y Avg
-474.62%
5Y Avg
-295.97%
Market Cap
$2.59M
Return on Equity (ROE)
-402.92%
TTM Avg
-276.14%
3Y Avg
-197.40%
5Y Avg
-116.89%
Market Cap
$1.92M
Return on Equity (ROE)
-509.36%
TTM Avg
-212.22%
3Y Avg
-233.92%
5Y Avg
-323.18%
Market Cap
$3.09M
Return on Equity (ROE)
-365.43%
TTM Avg
-2048.73%
3Y Avg
-1082.52%
5Y Avg
-614.77%
Market Cap
$3.13M
Return on Equity (ROE)
N/A
TTM Avg
-236.13%
3Y Avg
-104.67%
5Y Avg
-48.54%
Market Cap
$1.54M
Return on Equity (ROE)
-450.54%
TTM Avg
292.29%
3Y Avg
55.45%
5Y Avg
24.80%
Market Cap
$1.49M
Return on Equity (ROE)
-80.57%
TTM Avg
-96.07%
3Y Avg
-115.92%
5Y Avg
51.19%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Creative Medical Technology Holdings, Inc. (CELZ) | $2.37M | -69.79% | -86.99% | -75.38% | -73.35% |
| GeoVax Labs, Inc. (GOVX)vs › | $2.36M | -1160.10% | -528.10% | -389.86% | -336.02% |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.47M | -391.26% | -355.49% | -474.62% | -295.97% |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.59M | -402.92% | -276.14% | -197.40% | -116.89% |
| Autonomix Medical, Inc. (AMIX)vs › | $1.92M | -509.36% | -212.22% | -233.92% | -323.18% |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.09M | -365.43% | -2048.73% | -1082.52% | -614.77% |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.13M | N/A | -236.13% | -104.67% | -48.54% |
| Curis, Inc. (CRIS)vs › | $1.54M | -450.54% | 292.29% | 55.45% | 24.80% |
| PMGC Holdings Inc. (ELAB)vs › | $1.49M | -80.57% | -96.07% | -115.92% | 51.19% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.37M | -282.13% | -313.25% | -153.55% | -153.55% |
ROE
-69.8%
ROA
-64.4%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -69.79% |
| 2026-03-31 | -94.31% |
| 2025-12-31 | -79.78% |
| 2025-09-30 | -106.61% |
| 2025-06-30 | -84.45% |
| 2025-03-31 | -75.55% |
| 2024-12-31 | -86.63% |
| 2024-09-30 | -81.10% |
| 2024-06-30 | -75.29% |
| 2024-03-31 | -57.17% |
| 2023-12-31 | -51.11% |
| 2023-09-30 | -81.24% |
| 2023-06-30 | -68.12% |
| 2023-03-31 | -67.74% |
| 2022-12-31 | -63.94% |
| 2022-09-30 | -35.36% |
| 2022-06-30 | -37.60% |
| 2022-03-31 | -104.54% |
| 2021-12-31 | 188.02% |
| 2008-09-30 | -385.90% |
